Abstract
Although the frequency of activated Ki-ras genes is high in human colorectal tumors, much less is known of activated Ki-ras-mediated signaling pathways. Using gene targeting, we examined HCT116 cells that contain the Gly-13-->Asp mutation of Ki-ras and activated Ki-ras-disrupted clones derived from HCT116. 12-O-Tetradecanoylphorbol-13-acetate (TPA) induced immediate early genes, such as c-Jun, c-Fos, and Egr-1 in activated Ki-ras-disrupted clones, whereas c-Jun induction was rare in HCT116. TPA induced both phosphorylation of stress-activated protein kinase kinase 1 (SEK1) and c-Jun NH2-terminal kinase (JNK) in the activated Ki-ras-disrupted clones but not in HCT116. On the other hand, TPA-induced mitogen-activated protein kinase kinase 1/2 (MEK1/2)-extracellular signal-regulated kinase (ERK) activation was equally induced between HCT116 and the Ki-ras-disrupted clones. Furthermore, TPA-induced SEK1-JNK activation was observed in a DLD-1-derived activated Ki-ras-disrupted clone but not in DLD-1. The TPA-induced SEK1-JNK activation in these disrupted clones was completely inhibited by the protein kinase C (PKC) inhibitor, GF109203X (1 microM), but not by another PKC inhibitor, H7 (50 microM), whereas TPA-induced MEK1/2-ERK activation was partially and completely inhibited by GF109203X (1 microM) and H7 (50 microM), respectively. A phosphoinositol 3-kinase inhibitor, LY294002, did not inhibit the TPA-induced SEK1-JNK activation. Taken together, these results suggest that activated Ki-Ras-mediated signals are involved in the SEK1-JNK pathway through a PKC isotype that is distinct from that involved in MEK1/2-ERK activation in human colon cancer cells and independent of phosphoinositol 3-kinase activation, and the imbalance between ERK and JNK activity caused by activated Ki-Ras may play critical roles in human colorectal tumorigenesis.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Alleles
-
Amino Acid Substitution
-
Calcium-Calmodulin-Dependent Protein Kinases / metabolism*
-
Chromones / pharmacology
-
Colonic Neoplasms / genetics
-
Colonic Neoplasms / metabolism
-
Colonic Neoplasms / pathology*
-
Culture Media, Serum-Free / pharmacology
-
Depression, Chemical
-
Enzyme Activation / drug effects
-
Enzyme Inhibitors / pharmacology
-
Gene Expression Regulation, Neoplastic*
-
Genes, Immediate-Early
-
Genes, ras*
-
Humans
-
Indoles / pharmacology
-
Isoenzymes / antagonists & inhibitors
-
Isoenzymes / physiology
-
JNK Mitogen-Activated Protein Kinases
-
MAP Kinase Kinase 1
-
MAP Kinase Kinase 2
-
MAP Kinase Kinase 4*
-
MAP Kinase Kinase Kinase 1*
-
Maleimides / pharmacology
-
Mitogen-Activated Protein Kinase 3
-
Mitogen-Activated Protein Kinase Kinases*
-
Mitogen-Activated Protein Kinases*
-
Morpholines / pharmacology
-
Mutation, Missense
-
Neoplasm Proteins / metabolism*
-
Phosphatidylinositol 3-Kinases / physiology
-
Phosphoinositide-3 Kinase Inhibitors
-
Phosphorylation
-
Protein Isoforms / physiology
-
Protein Kinase C / antagonists & inhibitors
-
Protein Kinase C / physiology
-
Protein Kinases / metabolism*
-
Protein Processing, Post-Translational
-
Protein Serine-Threonine Kinases / metabolism
-
Protein-Tyrosine Kinases / metabolism
-
Proto-Oncogene Proteins p21(ras) / genetics
-
Proto-Oncogene Proteins p21(ras) / physiology*
-
Signal Transduction / drug effects*
-
Tetradecanoylphorbol Acetate / pharmacology*
-
Tumor Cells, Cultured
Substances
-
Chromones
-
Culture Media, Serum-Free
-
Enzyme Inhibitors
-
Indoles
-
Isoenzymes
-
Maleimides
-
Morpholines
-
Neoplasm Proteins
-
Phosphoinositide-3 Kinase Inhibitors
-
Protein Isoforms
-
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
-
Protein Kinases
-
MAP2K2 protein, human
-
Protein-Tyrosine Kinases
-
Protein Serine-Threonine Kinases
-
Protein Kinase C
-
Calcium-Calmodulin-Dependent Protein Kinases
-
JNK Mitogen-Activated Protein Kinases
-
Mitogen-Activated Protein Kinase 3
-
Mitogen-Activated Protein Kinases
-
MAP Kinase Kinase Kinase 1
-
MAP3K1 protein, human
-
MAP Kinase Kinase 1
-
MAP Kinase Kinase 2
-
MAP Kinase Kinase 4
-
MAP2K1 protein, human
-
MAP2K4 protein, human
-
Mitogen-Activated Protein Kinase Kinases
-
HRAS protein, human
-
Proto-Oncogene Proteins p21(ras)
-
bisindolylmaleimide I
-
Tetradecanoylphorbol Acetate